| 0 (0%) | 09-27 09:31 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 0.55 | 1-year : | 0.61 |
| Resists | First : | 0.47 | Second : | 0.52 |
| Pivot price | 0.42  |
|||
| Supports | First : | 0.39 | Second : | 0.32 |
| MAs | MA(5) : | 0.43 |
MA(20) : | 0.43 |
| MA(100) : | 0.55 |
MA(250) : | 0.71 |
|
| MACD | MACD : | -0.1  |
Signal : | -0.1 |
| %K %D | K(14,3) : | 46 |
D(3) : | 46 |
| RSI | RSI(14): 44.1 |
|||
| 52-week | High : | 1.44 | Low : | 0.3 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ PAVM ] has closed below upper band by 49.6%. Bollinger Bands are 55.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 4 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 0.44 - 0.44 | 0.44 - 0.44 |
| Low: | 0.4 - 0.4 | 0.4 - 0.41 |
| Close: | 0.42 - 0.43 | 0.43 - 0.43 |
Thu, 25 Sep 2025
Lucid Diagnostics Appoints John R. Palumbo To Board - citybiz
Thu, 18 Sep 2025
PAVmed Reports Q2 2025 Financial Results and Developments - MSN
Tue, 16 Sep 2025
Lucid Diagnostics Appoints Danielle Scelfo as Senior Vice President, Market Access & Government Affairs - PR Newswire
Wed, 10 Sep 2025
Lucid Diagnostics Announces Pricing of Public Offering of Common Stock - PR Newswire
Wed, 30 Jul 2025
PAVmed Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule - PR Newswire
Wed, 02 Jul 2025
Pulmonary Arterious Malformation as Rare Cause of ST-Segment Elevation Myocardial Infarction - JACC Journals
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | -12 (M) |
| Shares Float | -15 (M) |
| Held by Insiders | 1 (%) |
| Held by Institutions | 2.193e+007 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 16,110 (K) |
| EPS | -99.41 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -2.655e+007 |
| Profit Margin | 7 % |
| Operating Margin | 144.8 % |
| Return on Assets (ttm) | -78 % |
| Return on Equity (ttm) | 583.3 % |
| Qtrly Rev. Growth | 1 % |
| Gross Profit (p.s.) | 21.76 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | -1.9916e+006 |
| Qtrly Earnings Growth | -487000 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | -0.01 |
| Price to Sales | 0 |
| Price to Cash Flow | -1.11231e+006 |
| Dividend | 211300 |
| Forward Dividend | 10.64 |
| Dividend Yield | 49752800% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|